Published in Adv Nutr on November 01, 2012
Defective homocysteine metabolism: potential implications for skeletal muscle malfunction. Int J Mol Sci (2013) 0.99
Epigenetics in adipose tissue, obesity, weight loss, and diabetes. Adv Nutr (2014) 0.96
Interactions Between Nuclear Receptor SHP and FOXA1 Maintain Oscillatory Homocysteine Homeostasis in Mice. Gastroenterology (2015) 0.92
Contribution of endogenously produced reactive oxygen species to the activation of podocyte NLRP3 inflammasomes in hyperhomocysteinemia. Free Radic Biol Med (2013) 0.90
Potential of garlic (Allium sativum) in lowering high blood pressure: mechanisms of action and clinical relevance. Integr Blood Press Control (2014) 0.84
Impact of Maternal Diet on the Epigenome during In Utero Life and the Developmental Programming of Diseases in Childhood and Adulthood. Nutrients (2015) 0.81
Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review. World J Gastroenterol (2015) 0.80
The Molecular and Cellular Effect of Homocysteine Metabolism Imbalance on Human Health. Int J Mol Sci (2016) 0.80
Evaluation of Serum Homocysteine, High-Sensitivity CRP, and RBC Folate in Patients with Alopecia Areata. Indian J Dermatol (2014) 0.79
Homocysteinemia and early outcome of acute ischemic stroke in elderly patients. Brain Behav (2016) 0.78
Differential gene expression in the liver of the African lungfish, Protopterus annectens, after 6 months of aestivation in air or 1 day of arousal from 6 months of aestivation. PLoS One (2015) 0.78
Electrocardiogram Derived QRS Duration >120 ms is Associated With Elevated Plasma Homocysteine Levels in a Rural Australian Cross-Sectional Population. Medicine (Baltimore) (2015) 0.78
NADPH oxidase 4 regulates homocysteine metabolism and protects against acetaminophen-induced liver damage in mice. Free Radic Biol Med (2015) 0.76
Homocysteine as a Pathological Biomarker for Bone Disease. J Cell Physiol (2016) 0.76
One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling. Int J Mol Sci (2016) 0.75
Interactions between lifestyle and MTHFR polymorphisms on homocysteine concentrations in young adults belonging to the 1982 Pelotas Birth Cohort. Eur J Clin Nutr (2016) 0.75
Severe hyperhomocysteinemia due to cystathionine β-synthase deficiency, and Factor V Leiden mutation in a patient with recurrent venous thrombosis. Thromb J (2014) 0.75
Homocysteine: Friend or Foe? Integr Med (Encinitas) (2014) 0.75
Sulfheme formation during homocysteine S-oxygenation by catalase in cancers and neurodegenerative diseases. Nat Commun (2016) 0.75
Transient Decrease in Circulatory Testosterone and Homocysteine Precedes the Development of Metabolic Syndrome Features in Fructose-Fed Sprague Dawley Rats. J Nutr Metab (2016) 0.75
Homocysteine levels in women with a history of gestational diabetes mellitus. Diabetol Metab Syndr (2015) 0.75
Cochlear Homocysteine Metabolism at the Crossroad of Nutrition and Sensorineural Hearing Loss. Front Mol Neurosci (2017) 0.75
A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet (1995) 17.27
Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med (2006) 11.72
Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med (2006) 9.53
Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry (2008) 7.20
Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med (2010) 6.48
Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med (1991) 6.03
Homocysteine and cardiovascular disease. Annu Rev Med (1998) 4.69
Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation (1996) 4.62
Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med (2004) 3.32
The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J Biol Chem (1988) 2.69
Labile methyl balances for normal humans on various dietary regimens. Metabolism (1975) 2.53
Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci (2003) 2.21
Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care (1997) 2.18
Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr (1992) 2.03
Homocysteine, vitamins, and vascular disease prevention. Am J Clin Nutr (2007) 1.84
Competing methyltransferase systems. J Biol Chem (1972) 1.84
Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia. Am J Physiol Endocrinol Metab (2010) 1.74
Genetic effects of methylation diets. Annu Rev Nutr (2002) 1.70
Modulation of cystathionine beta-synthase level regulates total serum homocysteine in mice. Circ Res (2004) 1.68
Is it time to reevaluate methyl balance in humans? Am J Clin Nutr (2006) 1.61
Nutrition and aberrant DNA methylation patterns in atherosclerosis: more than just hyperhomocysteinemia? J Nutr (2005) 1.53
Feedback inhibition of methylene-tetrahydrofolate reductase in rat liver by S-adenosylmethionine. Biochim Biophys Acta (1967) 1.53
The homocysteine paradox. Arterioscler Thromb Vasc Biol (2008) 1.50
Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice. Circ Res (2001) 1.50
A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people. Clin Nutr (2011) 1.46
Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research. Br J Cancer (2011) 1.44
An unexpected requirement for phosphatidylethanolamine N-methyltransferase in the secretion of very low density lipoproteins. J Biol Chem (2002) 1.43
Inhibition of glycine N-methyltransferase activity by folate derivatives: implications for regulation of methyl group metabolism. Biochem Biophys Res Commun (1985) 1.42
Phosphatidylethanolamine N-methyltransferase (PEMT) gene expression is induced by estrogen in human and mouse primary hepatocytes. FASEB J (2007) 1.42
Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J Inherit Metab Dis (2006) 1.42
Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas. J Biol Chem (2011) 1.40
Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice. Stroke (2004) 1.37
Labile methyl group balances in the human: the role of sarcosine. Metabolism (1980) 1.34
Murine models of hyperhomocysteinemia and their vascular phenotypes. Arterioscler Thromb Vasc Biol (2008) 1.33
A glycine N-methyltransferase knockout mouse model for humans with deficiency of this enzyme. Transgenic Res (2006) 1.33
Methylation demand and homocysteine metabolism: effects of dietary provision of creatine and guanidinoacetate. Am J Physiol Endocrinol Metab (2001) 1.25
Homocysteine, B-vitamins and CVD. Proc Nutr Soc (2008) 1.21
Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia. Blood (2006) 1.20
Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am J Gastroenterol (2005) 1.18
Hormonal regulation of cystathionine beta-synthase expression in liver. J Biol Chem (2002) 1.10
Effect of Mthfr genotype on diet-induced hyperhomocysteinemia and vascular function in mice. Blood (2003) 1.09
MTHFR 677 C>T Polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis. Circulation (2009) 1.09
Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations. Arch Neurol (2004) 1.05
Physiological regulation of phospholipid methylation alters plasma homocysteine in mice. J Biol Chem (2005) 1.04
Effect of mechanical ventilation on carotid artery thrombosis induced by photochemical injury in mice. J Thromb Haemost (2003) 1.02
Effects of diabetes and insulin on betaine-homocysteine S-methyltransferase expression in rat liver. Am J Physiol Endocrinol Metab (2005) 1.01
Labile methyl groups and the promotion of cancer. Annu Rev Nutr (1986) 1.01
Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. Diabetes (1998) 1.00
Midlife homocysteine and late-life dementia in women. A prospective population study. Neurobiol Aging (2009) 0.98
Tissue-specific alterations of methyl group metabolism with DNA hypermethylation in the Zucker (type 2) diabetic fatty rat. Diabetes Metab Res Rev (2012) 0.97
Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases. Aliment Pharmacol Ther (2011) 0.97
Differential effects of homocysteine and beta aminopropionitrile on preosteoblastic MC3T3-E1 cells. Bone (2009) 0.97
Mesenteric vascular remodeling in hyperhomocysteinemia. Mol Cell Biochem (2010) 0.96
Dietary intake of S-(alpha-carboxybutyl)-DL-homocysteine induces hyperhomocysteinemia in rats. Nutr Res (2010) 0.95
Homocysteine enhances apoptosis in human bone marrow stromal cells. Bone (2006) 0.95
Homocysteine metabolism and its relation to health and disease. Biofactors (2010) 0.95
Blood S-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathy. Metabolism (2001) 0.95
Normalization of hyperhomocysteinemia improves cognitive deficits and ameliorates brain amyloidosis of a transgenic mouse model of Alzheimer's disease. FASEB J (2010) 0.94
Increased levels of homocysteine in patients with Crohn's disease are related to folate levels. Am J Gastroenterol (2000) 0.94
Effects of insulin on methionine and homocysteine kinetics in type 2 diabetes with nephropathy. Diabetes (2005) 0.92
Hyperglucagonemia in rats results in decreased plasma homocysteine and increased flux through the transsulfuration pathway in liver. J Biol Chem (2001) 0.90
Modulation of methyl group metabolism by streptozotocin-induced diabetes and all-trans-retinoic acid. J Biol Chem (2004) 0.90
The association between homocysteine and myocardial infarction is independent of age, sex, blood pressure, cholesterol, smoking and markers of inflammation: the Glasgow Myocardial Infarction Study. Blood Coagul Fibrinolysis (2006) 0.88
Plasma total cysteine and cardiovascular risk burden: action and interaction. ScientificWorldJournal (2012) 0.88
Homocysteine as a predictor of cognitive decline in Alzheimer's disease. Int J Geriatr Psychiatry (2010) 0.87
Hyperhomocysteinemia decreases bone blood flow. Vasc Health Risk Manag (2011) 0.86
Associations of plasma homocysteine levels with arterial stiffness in prehypertensive individuals. Clin Exp Hypertens (2011) 0.86
The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial. Clin Chem Lab Med (2007) 0.86
Type 1 diabetes mellitus and homocyst(e)ine. Diabete Metab (1995) 0.85
Folate status modulates the induction of hepatic glycine N-methyltransferase and homocysteine metabolism in diabetic rats. Am J Physiol Endocrinol Metab (2006) 0.85
Hyperhomocysteinemia induces a tissue specific accumulation of homocysteine in bone by collagen binding and adversely affects bone. Bone (2008) 0.85
Plasma total homocysteine is a determinant of carotid intima-media thickness and circulating endothelial progenitor cells in patients with newly diagnosed hypertension. Clin Chem Lab Med (2012) 0.85
Clinical course in Parkinson's disease with elevated homocysteine. Parkinsonism Relat Disord (2005) 0.84
Hepatic phosphatidylethanolamine N-methyltransferase expression is increased in diabetic rats. J Nutr (2006) 0.84
Insulin administration abrogates perturbation of methyl group and homocysteine metabolism in streptozotocin-treated type 1 diabetic rats. Am J Physiol Endocrinol Metab (2011) 0.83
MMP-9, homocysteine and CRP circulating levels are associated with intraluminal thrombus thickness of abdominal aortic aneurysms: new implication of the old biomarkers. Dis Markers (2011) 0.81
Isotretinoin use and the risk of inflammatory bowel disease. Am J Gastroenterol (2011) 0.81
The role of nutrition in neural tube defects. Annu Rev Nutr (1990) 0.80
Cardiovascular effects of B-vitamins and/or N-3 fatty acids: the SU.FOL.OM3 trial. Int J Cardiol (2012) 0.80
Serum homocysteine and physical exercise in patients with Parkinson's disease. Psychogeriatrics (2011) 0.79
Correction of endothelial dysfunction after selective homocysteine lowering gene therapy reduces arterial thrombogenicity but has no effect on atherogenesis. J Mol Med (Berl) (2011) 0.79
Elevated plasma homocysteine levels in patients on isotretinoin therapy for cystic acne. Int J Dermatol (2001) 0.79
Cysteine, homocysteine and bone mineral density: a role for body composition? Bone (2009) 0.79
Homocysteine-lowering therapy or antioxidant therapy for bone loss in Parkinson's disease. Mov Disord (2010) 0.79
Hyperhomocysteinemia decreases intestinal motility leading to constipation. Am J Physiol Gastrointest Liver Physiol (2012) 0.79
Relationship between serum homocysteine levels and depressive symptoms: the Cooper Center Longitudinal Study. J Clin Psychiatry (2012) 0.78
Testing homocysteine-induced neurotransmitter deficiency, and depression of mood hypothesis in clinical practice. Age Ageing (2011) 0.78
Plasma homocysteine levels and major depressive disorders in Alzheimer disease. Am J Geriatr Psychiatry (2010) 0.78
Nutritional therapies in Parkinson's disease. Curr Treat Options Neurol (2007) 0.76